More than 285,000 hip replacement surgeries took place in the United States in 2012, a 25% increase over the past five years. The increase occurred despite the number of failing metal-on-metal hip replacements, such as the Biomet M2A Magnum hip replacement.
Many surgeons attribute the rising number of hip implant surgeries to aging baby-boomers, as well as revision surgeries required due to faulty hip implants. A large majority of the hip replacements were metal-on-metal devices.
The Biomet M2A Magnum is one of several implants that have come under scrutiny due to severe side effects. Patients who received an M2A Magnum hip implant have complained of implant fretting, premature loosening of the hip replacement, corrosion, tissue damage and toxic levels of metal in the blood stream.